These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
619 related articles for article (PubMed ID: 19336502)
61. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809 [TBL] [Abstract][Full Text] [Related]
62. Aspirin Plus Clopidogrel vs Aspirin Alone for Preventing Cardiovascular Events Among Patients at High Risk for Cardiovascular Events. Donadini MP; Bellesini M; Squizzato A JAMA; 2018 Aug; 320(6):593-594. PubMed ID: 30054611 [TBL] [Abstract][Full Text] [Related]
63. Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes. Guimarães PO; Peterson ED; Stevens SR; Lokhnygina Y; Green JB; McGuire DK; Holman RR; Lopes RD Int J Cardiol; 2019 Aug; 289():58-62. PubMed ID: 31079973 [TBL] [Abstract][Full Text] [Related]
64. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. Chan FK; Ching JY; Hung LC; Wong VW; Leung VK; Kung NN; Hui AJ; Wu JC; Leung WK; Lee VW; Lee KK; Lee YT; Lau JY; To KF; Chan HL; Chung SC; Sung JJ N Engl J Med; 2005 Jan; 352(3):238-44. PubMed ID: 15659723 [TBL] [Abstract][Full Text] [Related]
65. Clopidogrel trial in patients with elective percutaneous coronary intervention for stable angina and old myocardial infarction (CLEAN). Isshiki T; Kimura T; Ueno T; Nakamura M; Igarashi K; Yokoi H; Kobayashi M; Ikari Y Int Heart J; 2012; 53(2):91-101. PubMed ID: 22688312 [TBL] [Abstract][Full Text] [Related]
66. The ACTIVE pursuit of stroke prevention in patients with atrial fibrillation. Go AS N Engl J Med; 2009 May; 360(20):2127-9. PubMed ID: 19439748 [No Abstract] [Full Text] [Related]
67. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Chen ZM; Jiang LX; Chen YP; Xie JX; Pan HC; Peto R; Collins R; Liu LS; Lancet; 2005 Nov; 366(9497):1607-21. PubMed ID: 16271642 [TBL] [Abstract][Full Text] [Related]
69. Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A]). Perera KS; Pearce LA; Sharma M; Benavente O; Connolly SJ; Hart RG; Am J Cardiol; 2018 Mar; 121(5):584-589. PubMed ID: 29291887 [TBL] [Abstract][Full Text] [Related]
70. Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial. Diener HC; Eikelboom J; Connolly SJ; Joyner CD; Hart RG; Lip GY; O'Donnell M; Hohnloser SH; Hankey GJ; Shestakovska O; Yusuf S; Lancet Neurol; 2012 Mar; 11(3):225-31. PubMed ID: 22305462 [TBL] [Abstract][Full Text] [Related]
71. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Hansen ML; Sørensen R; Clausen MT; Fog-Petersen ML; Raunsø J; Gadsbøll N; Gislason GH; Folke F; Andersen SS; Schramm TK; Abildstrøm SZ; Poulsen HE; Køber L; Torp-Pedersen C Arch Intern Med; 2010 Sep; 170(16):1433-41. PubMed ID: 20837828 [TBL] [Abstract][Full Text] [Related]
72. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation; 1991 Aug; 84(2):527-39. PubMed ID: 1860198 [TBL] [Abstract][Full Text] [Related]
73. Antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks. Koudstaal PJ Cochrane Database Syst Rev; 2000; (2):CD000186. PubMed ID: 10796314 [TBL] [Abstract][Full Text] [Related]
74. [Adding aspirin to clopidogrel in secondary prevention of ischemic stroke: no significant benefits. Results of the Match study]. Calvet D; Touzé E; Mas JL Presse Med; 2006 Apr; 35(4 Pt 2):679-82. PubMed ID: 16614614 [TBL] [Abstract][Full Text] [Related]
75. [New aspects on "triple therapy" after coronary stent implantation]. Schlitt A Dtsch Med Wochenschr; 2010 Oct; 135(41):2033-6. PubMed ID: 20925012 [TBL] [Abstract][Full Text] [Related]
76. Clopidogrel with or without omeprazole in coronary artery disease. Bhatt DL; Cryer BL; Contant CF; Cohen M; Lanas A; Schnitzer TJ; Shook TL; Lapuerta P; Goldsmith MA; Laine L; Scirica BM; Murphy SA; Cannon CP; N Engl J Med; 2010 Nov; 363(20):1909-17. PubMed ID: 20925534 [TBL] [Abstract][Full Text] [Related]
77. [Incidence of complications of antithrombotic treatment in patients with atrial fibrillation]. Novaković Anucin S; Gnip S; Canak V; Radović P; Kovacev J; Mitić G Med Pregl; 2013; 66(11-12):470-5. PubMed ID: 24575635 [TBL] [Abstract][Full Text] [Related]
78. The effectiveness and safety of dual antiplatelet therapy in ischemic cerebrovascular disease with intracranial and extracranial arteriostenosis in Chinese patients: A randomized and controlled trail. Zuo FT; Liu H; Wu HJ; Su N; Liu JQ; Dong AQ Medicine (Baltimore); 2017 Jan; 96(1):e5497. PubMed ID: 28072691 [TBL] [Abstract][Full Text] [Related]
79. Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events. Harker LA; Boissel JP; Pilgrim AJ; Gent M Drug Saf; 1999 Oct; 21(4):325-35. PubMed ID: 10514023 [TBL] [Abstract][Full Text] [Related]